Global Feed Antibiotics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Type (Tetracyclines (65.0% share in 2025), Macrolides (fastest CAGR: 3.8% from 2026 to 2031)), By Animal Type (Poultry (38.0% share in 2025), Poultry (fastest CAGR: 4.0% from 2026 to 2031)), By Region, By Company 2021-2031F 2021-2031F

Key Insights	Details
Forecast Period	2026 - 2031
Market Size (2025)	USD 3.83 Billion
CAGR (2026-2031)	3.68%
Fastest Growing Segment	Macrolides
Largest Market	Asia Pacific
Market Size (2031)	USD 4.76 Billion

Market Overview

The Global Feed Antibiotics Market is expected to grow from USD 3.83 Billion in 2025 to USD 4.76 Billion by 2031 at a 3.68% CAGR. Feed antibiotics are antimicrobial compounds incorporated into animal feed to prevent and treat bacterial infections, improve animal health, and enhance feed efficiency. The market's expansion is fundamentally driven by the escalating global demand for animal protein, stemming from population growth and rising incomes, which necessitates efficient livestock production to meet consumption needs. Additionally, the essential role of these compounds in disease prevention and control within intensive farming systems, coupled with their ability to improve feed conversion rates and promote animal growth, significantly supports market impetus.

According to World Grain, in 2025, global feed production reached 1.44 billion tons, marking a 3% increase from the previous year, highlighting the substantial scale of the broader industry where feed antibiotics are utilized. However, a notable impediment to market growth is the increasing global concern over antimicrobial resistance. This concern has led to more stringent regulatory restrictions and bans on the non-therapeutic application of antibiotics in animal feed across various regions, potentially curtailing future market expansion.

Key Market Drivers

Rising animal protein demand drives the feed antibiotics market
Rising global demand for animal protein significantly propels the feed antibiotics market. As the world population expands and incomes rise, there is an increasing consumption of meat, dairy, and eggs. This escalating demand necessitates highly efficient and large-scale livestock production systems, where animal health and productivity are paramount. Feed antibiotics play a critical role in these intensive farming environments by preventing diseases and promoting growth, thereby helping producers meet the substantial consumer appetite. According to the Food and Agriculture Organization (FAO), in its June 2026 "Food Outlook" report, global poultry meat production is projected to increase by 2.5% in 2026 compared to 2025, reaching over 160 million metric tons, highlighting the scale of the sector reliant on these compounds.

Livestock disease incidence as a key driver for feed antibiotics
The increased incidence of livestock diseases represents another pivotal driver for the global feed antibiotics market. Intensive commercial livestock farming, while efficient, can create conditions conducive to the rapid spread of bacterial infections. Outbreaks of diseases can lead to substantial economic losses for farmers through reduced productivity, mortality, and treatment costs. Feed antibiotics are essential for mitigating these risks, acting as a crucial tool for both proactive disease prevention and effective treatment of existing infections within herds and flocks, thereby safeguarding animal welfare and producer profitability. According to BEACON, in February 2026, approximately 6.43 million poultry were lost in December 2025 due to highly pathogenic avian influenza outbreaks, primarily in Asia and Europe. Moreover, according to Elanco Animal Health, in 2026, their third-quarter revenue reached $1.265 billion, marking an 11% increase compared to the third quarter of 2025, underscoring the dynamic nature of the broader animal health industry.

Download Free Sample Report

Key Market Challenges

Regulatory tightening constrains feed antibiotics and market growth
The increasing global concern over antimicrobial resistance presents a significant challenge to the growth of the Global Feed Antibiotics Market. This escalating concern has directly led to more stringent regulatory restrictions and outright bans on the non-therapeutic application of antibiotics in animal feed across various regions. Such measures directly curtail the volume of feed antibiotics that can be legally sold and utilized, thereby constraining market expansion. The shift in regulatory landscape compels livestock producers to reduce their reliance on these compounds, impacting sales revenue and market size.

Industry commitments and regulatory bans accelerate reduction in antibiotic use
This regulatory pressure is actively fostering a reduction in antibiotic use in animal agriculture. According to HealthforAnimals, in July 2026, the global animal health sector successfully met or exceeded 23 of its 25 commitments outlined in the Roadmap to Reducing the Need for Antibiotics by 2025. These commitments aimed at improving disease prevention and reducing the overall need for antibiotics, directly decreasing the demand for feed antibiotics. The ongoing implementation of bans, such as the European Union's restrictions on imports of animal products using growth-promoting antibiotics from 2026, further diminishes potential market avenues and compels the industry to adapt away from antibiotic-centric feed strategies.

Key Market Trends

Adoption of antibiotic-alternative feed additives and holistic health approaches
The shift towards antibiotic alternatives in animal feed represents a significant trend, reflecting the industry's proactive response to regulatory pressures and increasing consumer demand for reduced antibiotic use. Livestock producers are increasingly adopting feed additives such as probiotics, prebiotics, organic acids, and essential oils to maintain gut health and enhance animal performance without relying on antibiotics. This shift is driven by the understanding that a robust immune system and balanced gut microbiota can effectively prevent infections. According to Cargill Animal Nutrition & Health, in November 2025, their Micronutrition & Health Solutions business, which includes a range of non-antibiotic feed additives, has experienced double-digit growth each year for the past three years as customers increasingly adopt science-based nutrition solutions. This focus on holistic approaches fosters natural resistance and improves overall animal welfare, thereby diminishing the necessity for therapeutic or growth-promoting antibiotics.

Advances in precision animal health and nutrition enabling targeted management
Advancements in precision animal health and nutrition are significantly influencing the market by enabling more targeted and efficient management of livestock. Innovations include sensor-based monitoring systems, data analytics, and individualized feeding programs that optimize nutrient delivery and identify health issues early. These technologies allow for preemptive interventions and precise nutritional adjustments, reducing the overall disease burden and minimizing situations where antibiotics would traditionally be applied. According to Nedap, in 2024, their cow monitoring platform connected over 8 million cows worldwide, providing insights on health, reproduction, behavior, and location to enable better decision-making for farmers. By tailoring health and nutrition strategies to individual animal needs or specific farm conditions, the reliance on broad-spectrum antibiotic use is systematically curtailed.

Segmental Insights

Macrolides: Fastest-Growing Segment Fueled by Livestock Respiratory and Enteric Disease Control
The Macrolides segment is identified as the fastest-growing category within the Global Feed Antibiotics Market, a trend primarily attributed to their critical role in effectively managing widespread respiratory and enteric disease complexes in livestock. These antibiotics are highly valued for their specific efficacy in combating bacterial infections that commonly affect the respiratory and digestive systems of food-producing animals. Their mechanism of action, which involves inhibiting bacterial protein synthesis, contributes significantly to their therapeutic success. This targeted effectiveness, coupled with their utility in administering group medication for prevalent infections under veterinary supervision, positions Macrolides as an indispensable tool for maintaining animal health and productivity in intensive farming practices, thereby driving their rapid market expansion.

Regional Insights

Drivers Behind Asia Pacific's Lead in Feed Antibiotics
Asia Pacific leads the Global Feed Antibiotics Market due to a confluence of factors. The region experiences substantial demand for animal-derived protein products, driven by rising populations, increasing disposable incomes, and rapid urbanization, particularly in major economies like China and India. This increased consumption fuels the expansion of industrial livestock production, including intensive poultry, swine, and aquaculture farming, where feed antibiotics are utilized for disease prevention and to enhance productivity. Furthermore, while some countries are transitioning to alternatives, controlled use of feed antibiotics for animal health and growth promotion remains prevalent in many parts of Asia Pacific, supported by their cost-effectiveness and ongoing advancements in feed additive formulations. The sustained growth in animal husbandry and the emphasis on optimizing animal health and feed conversion ratios underpin the region's dominance.

Recent Developments

• In August 2025, Evonik Corp. submitted a formal petition to the U.S. Food and Drug Administration (FDA) to amend food additive regulations. The petition requested approval for the use of Bacillus velezensis as a probiotic in animal feed across all species. This strategic move positioned Evonik at the forefront of efforts to introduce next-generation feed additives that promote animal health while actively reducing the reliance on conventional antibiotics. The proposed probiotic aimed to improve gut health and nutrient utilization as a sustainable alternative.
• In June 2025, Innovad Group, a global leader in animal health and nutrition solutions, entered into a long-term exclusive supply agreement with ChainCraft. ChainCraft specializes in producing sustainable chemicals from food waste. Under this agreement, ChainCraft was to supply high-purity butyric acid and other fatty acids to Innovad. This collaboration enabled the production of low-carbon advanced feed additives designed to support animal intestinal health and environmental sustainability, offering an alternative approach to maintaining livestock well-being within the feed antibiotics market.
• In September 2024, Novus International, Inc. announced a collaboration with Ginkgo Bioworks, a biotechnology company, to develop advanced feed additives. This partnership aimed to leverage Ginkgo's enzyme services to create more efficient and cost-effective enzymes. The goal of these new feed additives was to address the evolving requirements of the animal agriculture sector by optimizing livestock health and performance. This initiative sought to reduce the reliance on traditional methods, impacting the feed antibiotics market by providing innovative nutritional solutions.
• In March 2024, Elanco Animal Health filed a patent for innovative antimicrobial feed supplement compositions. These compositions were designed to contain specific types of clay, sourced from regions such as Crater Lake in Oregon. The primary objective of this research was to combat microbial infections in animals and thereby enhance their growth performance. This development represented a strategic advancement in the global feed antibiotics market by offering alternative compounds to manage animal health and productivity in livestock feed.

Key Market Players

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Phibro Animal Health Corporation
• Huvepharma EOOD
• ECO Animal Health Group plc
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Cargill, Incorporated
• Virbac
• Ceva Santé Animale

By Type	By Animal Type	By Region
Tetracyclines (65.0% share in 2025) Macrolides (fastest CAGR: 3.8% from 2026 to 2031)	Poultry (38.0% share in 2025) Poultry (fastest CAGR: 4.0% from 2026 to 2031)	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Feed Antibiotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Feed Antibiotics Market, By Type:

• Tetracyclines (65.0% share in 2025)
• Macrolides (fastest CAGR: 3.8% from 2026 to 2031)

• Feed Antibiotics Market, By Animal Type:

• Poultry (38.0% share in 2025)
• Poultry (fastest CAGR: 4.0% from 2026 to 2031)

• Feed Antibiotics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE